US equities |
MU $1,035.84 ▼-4.79% NVDA $230.48 ▼-2.94% SNDK $1,609.46 ▼-4.90% AMD $620.68 ▼-3.90% INTC $107.08 ▼-5.34% AAPL $340.42 ▲+1.11% SPCX $160.57 ▼-4.19% META $720.89 ▼-0.06%
FinancialContent

OraSure Technologies, Inc. - Common Stock (NQ:OSUR)

3.795 +0.065 (+1.74%)
Delayed Quote Updated: 4:00 PM EDT, Oct 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about OraSure Technologies, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Hedge Fund Reportedly Prepares To Launch Board Fight At OraSure Technologies: Retail Investors Believe It’s Good News ↗
Altai Capital Management is one of the largest owners of OraSure and has increased its stake from 3% at the end of June to 5% in recent weeks, in an effort to press for board representation, Reuters... 
Via Stocktwits
News headline image
OraSure Receives Warning From Ron Zwanziger: Entrepreneur Warns Of Adversarial Path If Board Continues To Refuse Buyout Offer ↗
Zwanziger made an unsolicited all-cash offer for the company earlier in the summer but was rebuffed. 
Via Stocktwits
News headline image
OraSure (OSUR) Q2 Revenue Falls 43% ↗
Via The Motley Fool
Topics Economy
News headline image
OraSure Announces Second Quarter 2025 Financial Results
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For August 5, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 7, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 25, 2025 ↗
 
Via Benzinga
News headline image
OraSure Appoints Anne Messing as Chief Commercial Officer
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
OraSure to Announce Second Quarter 2025 Financial Results and Host Earnings Call on August 5th
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
OraSure Launches Novel Blood Collection Device for Proteomic Research
The device has the potential to transform proteomic discovery through extended protein stabilization and a simplified workflow for research 
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
Targeted Genomics Announces Commercial Collaboration with OraSure Technologies for Direct to Consumer (DTC) Celiac Genetic Testing
From Targeted Genomics
Via GlobeNewswire
News headline image
OraSure Announces First Quarter 2025 Financial Results
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
OraSure to Announce First Quarter 2025 Financial Results and Host Earnings Call on May 7th
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
OraSure Announces $40 Million Stock Repurchase Program
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
What's going on in today's session ↗
Wondering how the US markets performed one hour before the close of the markets on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill
News headline image
Here are the top movers in Wednesday's session. ↗
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
News headline image
Traders are paying attention to the gapping stocks in Wednesday's session. ↗
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Wednesday. 
Via Chartmill
News headline image
OraSure Reports Fourth Quarter 2024 Financial Results
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
OraSure to Announce Fourth Quarter 2024 Financial Results and Host Earnings Call on February 25th
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
OraSure to Present at the J.P Morgan Healthcare Conference
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
CORRECTION - OraQuick® HIV Self-Test Now Approved for Use in Adolescents
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
OraQuick® HIV Self-Test Now Approved for Use in Adolescents
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
OraSure Technologies Acquires Sherlock Biosciences
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
OraSure Receives Federal Funding for Development of Marburg Virus Rapid Antigen Test
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
OraSure to Participate in Upcoming Investor Conference
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
OraSure Reports Q3 ’24 Revenue of $39.9 Million
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
OraSure to Announce Third Quarter 2024 Financial Results and Host Earnings Call on November 6th
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
OraSure Technologies Elects Jack Kenny to the Board of Directors
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
OSUR Stock Earnings: OraSure Technologies Beats EPS, Beats Revenue for Q2 2024 ↗
OSUR stock results show that OraSure Technologies beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
OraSure Reports Q2 ’24 Revenue of $54.3 Million
From OraSure Technologies, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 Next >